BPDE-induced lymphocytic 3p21.3 aberrations may predict head and neck carcinoma risk

Cancer

Volumn 95, Issue 3, 2002, Pages 563-568

  Zhu, Yong ^a   Spitz, Margaret R ^a   Zheng, Yun Ling ^b   Hong, Waun K ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

BPDE; Chromosomal aberration; FISH; HNSCC

Indexed keywords

CARCINOGEN; DIHYDROXYBENZO[A]PYRENE OXIDE;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CELL CULTURE; CHROMOSOME ABERRATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC SUSCEPTIBILITY; HEAD AND NECK CARCINOMA; HUMAN; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TOBACCO;

7,8-DIHYDRO-7,8-DIHYDROXYBENZO(A)PYRENE 9,10-OXIDE; AGED; CARCINOGENS; CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEAD AND NECK NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS;

EID: 0036682323     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10689     Document Type: Article

References (29)

1. Early genetic and functional events in the pathogenesis of oral cancer
2. Biology, cytogenetics, and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines
3. Three distinct regions involved in 3p deletions in human lung cancer
4. Three discrete regions of deletion at 3p in head and neck cancers
5. Allelic loss at chromosome 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer
6. Allelotype of head and neck squamous cell carcinoma
7. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma
8. A homozygous deletion on chromosome 3 in a small cell lung cancer cell line correlates with a region of tumor suppressor activity
9. Definition of a tumor suppressor locus within human chromosome 3p21-p22
10. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
11. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
12. The expression of common fragile sites and genetic predisposition to squamous cell lung cancers
13. Nonrandom distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies
14. Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers
15. Benzo[a]pyrene diol epoxide-induced 3p21.3 aberrations and genetic predisposition to lung cancer
16. Constitutive fragile sites and cancer
17. Specific chromosome anomalies and predisposition to human breast, renal cell and colorectal carcinomas
18. Chromosome fragility and instability in human cancer
19. Retinoblastoma and subband deletion of chromosome 13
20. Familial occurrence of the aniridia Wilm's tumor syndrome with deletion 11p13-14.1
21. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma of the oral cavity
22. Three discrete regions of deletion at 3p in head and neck cancers
23. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and β-cat genes in squamous cell carcinoma of the head and neck
24. Chromosome fragility and instability in human cancer
25. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
26. Functional evidence for involvement of multiple tumor suppressor genes on the short arm of chromosome 3 in human oral squamous cell carcinogenesis
27. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control
28. Trinucleotide repeat length variation in the human ribosomal protein L14 gene (RPL14): Location to 3p21.3 and loss of heterozygosity in lung and oral cancers
29. Mutations in the arginine-rich protein gene in lung, breast, and prostate cancers, and in squamous cell carcinomas of the head and neck